LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: Locked in Mania.

    Goldberg, Joseph F / Ernst, Carrie L

    Journal of the Academy of Consultation-Liaison Psychiatry

    2023  Volume 64, Issue 6, Page(s) 574–575

    Language English
    Publishing date 2023-09-18
    Publishing country Netherlands
    Document type Letter
    ISSN 2667-2960
    ISSN (online) 2667-2960
    DOI 10.1016/j.jaclp.2023.06.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book: Managing the side effects of psychotropic medications

    Goldberg, Joseph F. / Ernst, Carrie L.

    2012  

    Author's details Joseph F. Goldberg ; Carrie L. Ernst
    Keywords Psychotropic Drugs / adverse effects
    Language English
    Size XXXV, 496 S.
    Edition 1. ed.
    Publisher American Psychiatric Publ
    Publishing place Washington, DC
    Publishing country United States
    Document type Book
    Note The psychiatrist as physician -- Pharmacokinetics, pharmacodynamics, and pharmacogenomics -- Vulnerable populations -- Adverse psychiatric effects of nonpsychotropic medications -- Adverse psychiatric effects of psychiatric medications -- What nonmedical therapists should know about adverse drug effects -- Cardiovascular system -- Dermatological system -- Ear, nose, and throat -- Electrolyte abnormalities -- Endocrinopathies -- Gastrointestinal system -- Genitourinary and renal systems -- Hematological system -- Musculoskeletal system -- Neurological system -- Ophthalmological system -- Sleep disturbances -- Systemic reactions -- Pregnancy and the puerperium -- Emergency situations -- Summary recommendations
    HBZ-ID HT017337925
    ISBN 978-1-58562-402-7 ; 1-58562-402-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Comment on "Is It Time to Rethink Psychiatry Residency Training? Part II: Training All Psychiatry Residents to Be General Psychiatrists".

    Lebin, Lindsay G / Mihalik-Wenger, Amanda / Ernst, Carrie L / Schwartz, Ann C / Soeprono, Thomas M

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry

    2024  

    Language English
    Publishing date 2024-01-26
    Publishing country United States
    Document type Letter
    ZDB-ID 1045331-3
    ISSN 1545-7230 ; 1042-9670
    ISSN (online) 1545-7230
    ISSN 1042-9670
    DOI 10.1007/s40596-024-01936-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: What to Do When Your Depressed Patient Develops Mania.

    Goldberg, Joseph F / Ernst, Carrie L

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS

    2017  Volume 33, Issue Suppl 2, Page(s) 26S–33S

    Abstract: When does mania signal bipolar disorder, another medical illness, or the adverse effects of a prescribed antidepressant? And what are the next steps to manage this development? ...

    Abstract When does mania signal bipolar disorder, another medical illness, or the adverse effects of a prescribed antidepressant? And what are the next steps to manage this development?
    Language English
    Publishing date 2017-12-12
    Publishing country United States
    Document type Journal Article
    ISSN 1945-337X
    ISSN (online) 1945-337X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Psychopharmacological Decision Making in Bipolar Disorder During Pregnancy and Lactation: A Case-by-Case Approach to Using Current Evidence.

    Albertini, Elizabeth / Ernst, Carrie L / Tamaroff, Rachel S

    Focus (American Psychiatric Publishing)

    2019  Volume 17, Issue 3, Page(s) 249–258

    Abstract: The safety of pharmacotherapy for bipolar disorder during pregnancy and lactation remains a subject of debate and uncertainty. Clinicians must balance concerns about anatomical and behavioral teratogenicity, maternal mental health, exposure to multiple ... ...

    Abstract The safety of pharmacotherapy for bipolar disorder during pregnancy and lactation remains a subject of debate and uncertainty. Clinicians must balance concerns about anatomical and behavioral teratogenicity, maternal mental health, exposure to multiple drugs, and heightened risks for peripartum mood episodes. Risk-benefit analyses must consider factors such as illness severity, past pregnancy treatment outcomes, known drug responsivity, psychosocial supports, and key windows during fetal development. Pharmacological decision making usually changes over the course of pregnancy, given developments in maternal physiology and critical relapse risk periods. Among mood stabilizers, given current research, many experts eschew divalproex and carbamazepine, consider lamotrigine relatively benign, and voice strong opinions for or against lithium. Most second-generation antipsychotics are considered relatively safe, apart from possible extrapyramidal and other motor signs of withdrawal after delivery. In this review, the authors analyze the practical questions, current controversies, and available evidence regarding psychotropic drug therapy during pregnancy and lactation in bipolar disorder.
    Language English
    Publishing date 2019-07-16
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1541-4094
    ISSN 1541-4094
    DOI 10.1176/appi.focus.20190007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Annual Meeting Content Analysis: Leveraging Annual Meetings to Promote Diversity, Equity, Inclusion, and Belonging in the Academy of Consultation-Liaison Psychiatry.

    Amonoo, Hermioni L / Khandai, Abhisek C / Boardman, Annabella C / Ernst, Carrie L / Fernandez-Robles, Carlos / Suarez, Laura / Bradley, Mark V / Forrester, Anique K / Dale, Ciara / Lee, Kewchang / Vaughn, Rubiahna / Mittal, Leena P

    Journal of the Academy of Consultation-Liaison Psychiatry

    2024  

    Abstract: Background: There is an increasing need to promote diversity, equity, and inclusion (DEI) in all aspects of academic medicine, including through continuing medical education. Although professional medical organizations' annual meetings play an ... ...

    Abstract Background: There is an increasing need to promote diversity, equity, and inclusion (DEI) in all aspects of academic medicine, including through continuing medical education. Although professional medical organizations' annual meetings play an instrumental role in continuing medical education for physicians, there are no studies describing DEI content in the annual meeting programming of professional medical organizations, including the Academy of Consultation-Liaison Psychiatry (ACLP), the primary professional organization for consultation-liaison psychiatrists.
    Objective: To examine the ACLP annual meeting titles using Content Analysis.
    Methods: We examined the publicly available ACLP annual meeting content titles on the ACLP website from 2010 to 2021. National DEI leaders from ACLP's DEI subcommittee iteratively generated keywords that covered a broad scope of DEI-related themes. Each annual meeting's content was independently coded by 2 members of the DEI subcommittee with discrepancies adjudicated by 2 additional members. Descriptive statistics were used to characterize the content of the annual meeting.
    Results: Of the 2615 annual meeting titles from 2010 to 2021 that were analyzed, 2531 were not coded to have DEI themes. Three percent (n = 84) of titles were coded to have a DEI theme as follows: Culture/diversity (n = 20, 24%), bias/disparities (n = 17, 20%), race/racism (n = 17, 20%), social justice (n = 12, 14%), gender/sexism (n = 10, 12%), and LGBTQ+ (n = 8, 10%). The frequency of DEI titles each year ranged from 1% (2010, 2018) to 17% (2021) with an increase in DEI content in 2021 (n = 24, 17%).
    Conclusions: Although professional medical organizations like the ACLP are poised to leverage their continuing medical education platforms embedded in annual meeting programming to train consultation-liaison psychiatrists on DEI topics, our findings suggest more work is needed to develop and promote DEI-focused educational programming for their annual meetings.
    Language English
    Publishing date 2024-02-22
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2667-2960
    ISSN (online) 2667-2960
    DOI 10.1016/j.jaclp.2024.02.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Core Concepts Involving Adverse Psychotropic Drug Effects: Assessment, Implications, and Management.

    Goldberg, Joseph F / Ernst, Carrie L

    The Psychiatric clinics of North America

    2016  Volume 39, Issue 3, Page(s) 375–389

    Abstract: Adverse effects from psychiatric drugs can profoundly influence treatment adherence and outcomes. Good care involves addressing adverse effects no differently than any other component of treatment. Knowledge about adverse effect assessment and management ...

    Abstract Adverse effects from psychiatric drugs can profoundly influence treatment adherence and outcomes. Good care involves addressing adverse effects no differently than any other component of treatment. Knowledge about adverse effect assessment and management fosters a proper context that helps clinicians not sacrifice a drug's potential therapeutic benefits because of greater concerns about its tolerability. This article provides an overview of basic concepts related to the assessment and management of suspected adverse effects from psychotropic drugs. Key points are discussed regarding clinical, pharmacogenetic, pharmacokinetic, and pharmacodynamic risk factors for treatment-emergent adverse effects, alongside recommendations for their systematic assessment.
    MeSH term(s) Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/etiology ; Drug-Related Side Effects and Adverse Reactions/genetics ; Drug-Related Side Effects and Adverse Reactions/therapy ; Humans ; Psychotropic Drugs/adverse effects
    Chemical Substances Psychotropic Drugs
    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 431518-2
    ISSN 1558-3147 ; 0193-953X
    ISSN (online) 1558-3147
    ISSN 0193-953X
    DOI 10.1016/j.psc.2016.04.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A 10-Year Follow-up Survey of Psychiatry Resident Education in Consultation-Liaison Psychiatry.

    Beach, Scott R / Ernst, Carrie L / Lavakumar, Mallika / Greenstein, Samuel P / Fipps, David C / Soeprono, Thomas M / Heinrich, Thomas W / Schwartz, Ann C

    Journal of the Academy of Consultation-Liaison Psychiatry

    2022  Volume 64, Issue 3, Page(s) 199–208

    Abstract: Background: In 2010, the Academy of Consultation-Liaison (then Academy of Psychosomatic Medicine) surveyed US residency programs to understand training in consultation-liaison (CL) psychiatry, leading to recommendations in 2014. Since then, residency ... ...

    Abstract Background: In 2010, the Academy of Consultation-Liaison (then Academy of Psychosomatic Medicine) surveyed US residency programs to understand training in consultation-liaison (CL) psychiatry, leading to recommendations in 2014. Since then, residency training in CL has evolved in the context of competing training demands, increased prioritization of electives, and reactions to coronavirus 2019.
    Objective: To determine the current state of residency training in CL across the United States, including the structure of core and elective resident rotations in CL, attending physician staffing, presence of fellows and other trainees, didactic curriculum, and impact of coronavirus 2019.
    Methods: Members of the Academy of Consultation-Liaison Residency Education Subcommittee designed and piloted an 81-question survey tool that was sent to program directors of 269 US general psychiatry training programs for voluntary completion.
    Results: One hundred three of 269 programs responded to the survey, yielding a response rate of 38.3%. Responding programs were larger and more likely to have a CL fellowship than nonresponding programs. Of the 103 responding programs, 82.5% have more than the minimally required time on CL, with 46.6% reporting an increase in total CL time in the past decade. Since 2010, 18.4% of responding programs changed the placement of the CL rotation, with 43.7% now adherent to the 2014 Academy of Psychosomatic Medicine recommendation to include core CL training in the second half of residency. Thirty-five percent of responding programs require residents to rotate on more than 1 CL service, and 19.4% have a required outpatient CL component. Faculty full-time equivalent varies widely. Of all services included, 33.8% report that all CL faculty are board-certified in CL psychiatry, whereas 18.7% have no board-certified faculty. Of the 103 responding programs, 36.9% offer a CL fellowship, but 31.1% report no residency graduates pursuing CL fellowships in the past 5 years. Of the included programs, 77.7% have a formal CL curriculum for residents, with 34.0% reporting a separate didactic series during the CL rotation.
    Conclusions: Among the responding programs, the amount of time spent on core CL rotations has increased in the past decade, but programs have also shifted CL training earlier in the course of residency. Residency programs are increasingly challenged to provide an optimal CL experience, and updated guidance from Academy of Consultation-Liaison may be appreciated.
    MeSH term(s) United States ; Internship and Residency ; Follow-Up Studies ; Psychiatry/education ; Curriculum ; Referral and Consultation
    Language English
    Publishing date 2022-12-12
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2667-2960
    ISSN (online) 2667-2960
    DOI 10.1016/j.jaclp.2022.12.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Psychopharmacology of COVID-19.

    Bilbul, Melanie / Paparone, Patricia / Kim, Anna M / Mutalik, Shruti / Ernst, Carrie L

    Psychosomatics

    2020  Volume 61, Issue 5, Page(s) 411–427

    Abstract: Background: With the rapid, global spread of severe acute respiratory syndrome coronavirus 2, hospitals have become inundated with patients suffering from coronavirus disease 2019. Consultation-liaison psychiatrists are actively involved in managing ... ...

    Abstract Background: With the rapid, global spread of severe acute respiratory syndrome coronavirus 2, hospitals have become inundated with patients suffering from coronavirus disease 2019. Consultation-liaison psychiatrists are actively involved in managing these patients and should familiarize themselves with how the virus and its proposed treatments can affect psychotropic management. The only Food and Drug Administration-approved drug to treat COVID-19 is remdesivir, and other off-label medications used include chloroquine and hydroxychloroquine, tocilizumab, lopinavir/ritonavir, favipiravir, convalescent plasma therapy, azithromycin, vitamin C, corticosteroids, interferon, and colchicine.
    Objective: To provide an overview of the major safety considerations relevant to clinicians who prescribe psychotropics to patients with COVID-19, both related to the illness and its proposed treatments.
    Methods: In this targeted review, we performed structured literature searches in PubMed to identify articles describing the impacts of COVID-19 on different organ systems, the neuropsychiatric adverse effects of treatments, and any potential drug interactions with psychotropics. The articles most relevant to this one were included.
    Results: COVID-19 impacts multiple organ systems, including gastrointestinal, renal, cardiovascular, pulmonary, immunological, and hematological systems. This may lead to pharmacokinetic changes that impact psychotropic medications and increase sensitivity to psychotropic-related adverse effects. In addition, several proposed treatments for COVID-19 have neuropsychiatric effects and potential interactions with commonly used psychotropics.
    Conclusions: Clinicians should be aware of the need to adjust existing psychotropics or avoid using certain medications in some patients with COVID-19. They should also be familiar with neuropsychiatric effects of medications being used to treat this disease. Further research is needed to identify strategies to manage psychiatric issues in this population.
    MeSH term(s) Adenosine Monophosphate/adverse effects ; Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Alanine/adverse effects ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Amides/adverse effects ; Amides/therapeutic use ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Ascorbic Acid/adverse effects ; Ascorbic Acid/therapeutic use ; Azithromycin/adverse effects ; Azithromycin/therapeutic use ; Betacoronavirus ; COVID-19 ; Chloroquine/adverse effects ; Chloroquine/therapeutic use ; Colchicine/adverse effects ; Colchicine/therapeutic use ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/metabolism ; Coronavirus Infections/therapy ; Drug Combinations ; Drug Interactions ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Immunization, Passive ; Interferons/adverse effects ; Interferons/therapeutic use ; Lopinavir/adverse effects ; Lopinavir/therapeutic use ; Mental Disorders/chemically induced ; Mental Disorders/complications ; Mental Disorders/drug therapy ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/metabolism ; Psychotropic Drugs/adverse effects ; Psychotropic Drugs/metabolism ; Psychotropic Drugs/therapeutic use ; Pyrazines/adverse effects ; Pyrazines/therapeutic use ; Ritonavir/adverse effects ; Ritonavir/therapeutic use ; SARS-CoV-2 ; Vitamins/adverse effects ; Vitamins/therapeutic use
    Chemical Substances Adrenal Cortex Hormones ; Amides ; Anti-Inflammatory Agents ; Antibodies, Monoclonal, Humanized ; Antiviral Agents ; Drug Combinations ; Psychotropic Drugs ; Pyrazines ; Vitamins ; lopinavir-ritonavir drug combination ; Lopinavir (2494G1JF75) ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Hydroxychloroquine (4QWG6N8QKH) ; Azithromycin (83905-01-5) ; Chloroquine (886U3H6UFF) ; Interferons (9008-11-1) ; favipiravir (EW5GL2X7E0) ; tocilizumab (I031V2H011) ; Ritonavir (O3J8G9O825) ; Alanine (OF5P57N2ZX) ; Ascorbic Acid (PQ6CK8PD0R) ; Colchicine (SML2Y3J35T)
    Keywords covid19
    Language English
    Publishing date 2020-05-18
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 209487-3
    ISSN 1545-7206 ; 0033-3182
    ISSN (online) 1545-7206
    ISSN 0033-3182
    DOI 10.1016/j.psym.2020.05.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Optimizing Fit: Targeting a Residency Psychiatry Consultation-Liaison Rotation to Various Levels of Training.

    Beach, Scott R / Shalev, Daniel / Fischel, Steven V / Boland, Robert J / Ernst, Carrie L

    Psychosomatics

    2020  Volume 61, Issue 6, Page(s) 645–654

    Abstract: Background: Determining the optimal timing and structure for a core residency rotation in consultation-liaison psychiatry (CLP) remains a key challenge for program directors and rotation leaders. Previous surveys have been conducted regarding these ... ...

    Abstract Background: Determining the optimal timing and structure for a core residency rotation in consultation-liaison psychiatry (CLP) remains a key challenge for program directors and rotation leaders. Previous surveys have been conducted regarding these questions, and guidelines from national organizations have been issued, but practices remain varied among institutions.
    Methods: We conducted a narrative review of the literature related to the timing of CLP rotations and generated consensus recommendations based on our experience as program directors, rotation leaders, and residents.
    Results: Explicit goals of CLP training in residency include identifying and treating psychiatric manifestation of medical illness and communicating effectively with primary teams. Implicit goals of training may includeconflict management, limit setting, and "thinking dirty."
    Discussion: Although CLP rotations earlier in residency often create a better fit within the overarching curriculum and allow for generating early interest in the field, significant amounts of supervision are required, and consultees may look to attendings as the primary consultant. Conversely, while later rotations are sometimes challenging to structure with other outpatient responsibilities, they allow for greater autonomy and may map better onto the informal curriculum. A hybrid model, with training spread across multiple years, is another approach that may mitigate some of the disadvantages of confining consultation-liaison training to a single year. Compelling arguments can be made for placing the core CLP rotation in postgraduate year 2 or 3 or using a hybrid model. Regardless of placement, program directors and rotation leaders should be mindful of tailoring the rotation to the trainees' developmental stage.
    MeSH term(s) Curriculum ; Education, Medical ; Humans ; Internship and Residency ; Psychiatry/education ; Referral and Consultation
    Keywords covid19
    Language English
    Publishing date 2020-07-17
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 209487-3
    ISSN 1545-7206 ; 0033-3182
    ISSN (online) 1545-7206
    ISSN 0033-3182
    DOI 10.1016/j.psym.2020.07.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top